Replies to post #419745 on Amarin Corp Plc (AMRN)

[Whalatane]

Jas. Sorry to read about your relatives . ATHA has a drug in development ..p2/3 trial . They had run earlier trials and allowed those in the earlier trials to stay on drug for long term follow up.
Some ...with mild to moderate cognitive decline .....have been on their drug for around 2 yrs .
Co is supposed to do a follow up analysis on these patients mid year .
Perceptive Advisors and Baker Bros have positions in ATHA .
Sorry this is OT but thought you might be interested
Kiwi